Bruegger's Joins Share Our Strength's Great American Dine Out, September 19-25, 2010

299 bakery locations to participate in week-long event to end childhood hunger in America.

2010-09-16

WASHINGTON, DC, September 16, 2010 (Press-News.org) Bruegger's Enterprises Inc. will join thousands of restaurants this month in a fight against childhood hunger during Share Our Strength's annual Great American Dine Out, a week-long national restaurant event in cities across the United States. Scheduled from September 19-25, 2010, the event raises funds for No Kid Hungry, Share Our Strength's national campaign to end childhood hunger in America by 2015 and help connect kids to the food they need to live healthy, active lives.

Bruegger's is asking its guests to join in this important cause. Beginning September 19, guests can purchase coupon books in any of the chain's 299 locations. A $20 value, the book is filled with discounts and free items to be used throughout the year. Most importantly, all proceeds from the $3 book will go directly to Share our Strength and its important mission of ending childhood hunger. More details are available at www.brueggers.com.

The Great American Dine Out raised nearly $800,000 in 2009 from 4,000 participating restaurants. Each year, generous restaurant partners donate a portion of the week's sales, offer special promotions or collect donations from their customers. This is Bruegger's second year of participation, and the bakery cafe operator hopes to double its contribution and raise at least $25,000 for the worthy cause.

"Bruegger's continually supports its neighbors in every community we serve, through national efforts and local fundraisers," said James J. Greco, CEO of Bruegger's. "Great American Dine Out gives us a way to engage customers in a worthy cause and to join with our industry colleagues to make a real difference in the lives of children."

For a list of participating restaurants and more information about Share out Strength's Great American Dine Out, please visit www.GreatAmericanDineOut.org.

About Bruegger's Enterprises, Inc.
Bruegger's Enterprises, Inc., an affiliate of Sun Capital Partners, Inc., is a leader in the fast casual restaurant segment. In its 299 locations in 26 states, the District of Columbia and Toronto, Bruegger's is dedicated to serving delicious, authentically made food that brings guests back again and again. Founded in 1983, Bruegger's is headquartered in Burlington, Vermont and supports its neighbors in every community it serves. For more information, please visit www.brueggers.com or become a fan on Facebook at www.facebook.com/brueggers.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Penny Auction Solutions, Inc. Secures $10 Million in Financing from Kodiak Capital Group, LLC

2010-09-16

Penny Auction Solutions, Inc. (PAS) is pleased to announce that it has signed an investment agreement with Kodiak Capital Group, LLC of New York City (Kodiak) for a $10 million equity line of credit. PAS plans to use the funding to establish operations and begin offering services in early 2011. Their strategic approach is tailored to capitalize on the online Penny Auction entertainment-shopping arena. One key advantage is their ability to penetrate the global marketplace with the top 291 Internet domains and .mobi's. PAS is preparing an S-1 Registration Statement ...

Study: Old age may not be to blame for becoming forgetful

2010-09-16

ST. PAUL, Minn. – New research suggests that old age may not play a role in why older people become forgetful. According to a study published in the September 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology, the same brain lesions that are associated with dementia are responsible for mild memory loss in old age. "It appears these brain lesions have a much greater impact on memory function in old age than we previously thought," said study author Robert S. Wilson, PhD, with Rush University Medical Center in Chicago. "Our ...

Global project underway to preserve yam biodiversity

2010-09-16

BENIN (16 September 2010)—Farmers and crop scientists worldwide are engaged in an ambitious new effort to add 3,000 yam samples to international genebanks with the aim of saving the diversity of a crop that is consumed by 60 million people on a daily basis in Africa alone, according to an announcement today from the Global Crop Diversity Trust. In almost all the countries of the African yam belt, a large number of potentially important yam varieties are preserved only in fields, where they are in danger of being picked off by pests or diseases as well as more common disasters ...

JAK inhibitor provides rapid, durable relief for myelofibrosis patients

2010-09-16

HOUSTON - An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at The University of Texas MD Anderson Cancer Center report in the Sept. 16 New England Journal of Medicine. Myelofibrosis is caused by the accumulation of malignant bone marrow cells that trigger an inflammatory response, scarring the bone marrow and limiting its ability to produce blood, causing anemia. "The problem with myelofibrosis is the lack of available therapies for patients - there are none approved ...

Scientists pave way for improved teamwork on collaborative research efforts

2010-09-16

Tackling today's complex scientific questions often requires work from interdisciplinary collaborative research teams – and working in those teams can create its own problems. Now a group of researchers from around the country, including North Carolina State University, has published a commentary in the journal Science Translational Medicine outlining a new field of study that will help resolve problems facing interdisciplinary research teams. The new area of study, called the "science of team science," or SciTS (rhymes with sights), focuses on what works and what doesn't ...

Johns Hopkins scientists find genes related to body mass

2010-09-16

Johns Hopkins scientists who specialize in unconventional hunts for genetic information outside nuclear DNA sequences have bagged a weighty quarry — 13 genes linked to human body mass. The experiments screened the so-called epigenome for key information that cells remember other than the DNA code itself and may have serious implications for preventing and treating obesity, the investigators say. "Some of the genes we found are in regions of the genome previously suspected but not confirmed for a link to body mass index and obesity," says co-lead investigator Andrew Feinberg, ...

The friendly way to catch the flu

2010-09-16

Your friends are probably more popular than you are. And this "friendship paradox" may help predict the spread of infectious disease. Nicholas Christakis, professor of medicine, medical sociology and sociology at Harvard University, and James Fowler, professor of medical genetics and political science at the University of California, San Diego, used the paradox to study the 2009 flu epidemic among 744 students. The findings, the researchers say, point to a novel method for early detection of contagious outbreaks. Analyzing a social network and monitoring the health ...

Modern Muslims use dreams to make major life decisions

2010-09-16

The traditional practice of using night dreams to make major life decisions is in widespread use among modern Muslims, reveals a new study whose author is speaking at the British Science Festival on Thursday September 16*. Interviews with 60 Muslims in the UK, North America, Europe and Pakistan have revealed that night dreams are being used to make choices on issues like marriage, business, career development and politics. Research leader, Durham University anthropologist Dr Iain Edgar focused on the centuries-old practice of Istikhara, or Islamic 'dream incubation'. ...

Genetic finding identifies male-linked mutation associated with autism spectrum disorders

2010-09-16

NEW YORK, N.Y. (September 15, 2010) – Autism Speaks, the world's largest autism science and advocacy organization, and an international consortium of researchers, along with participating families, joined together to announce additional new autism genetic discoveries. The results were published today in Science Translational Medicine. Based on analysis of genomes collected from almost 2,250 individuals, including almost 2,000 with ASD and 246 with intellectual disabilities, and more than 10,000 controls, the researchers found PTCHD1 mutations or copy number variant (CNV) ...

Depression and heart disease combo more lethal than either one alone

2010-09-16

The combination of depression and heart disease seems to be far more lethal than having either one of these conditions in isolation, suggests research published online in Heart. Previous research has indicated that people who are depressed, but otherwise healthy, are more likely to develop coronary heart disease, irrespective of what other risk factors they might have. And people who are depressed are more likely to die from all causes, but it still remains unclear as to whether depression is more fatal for those with heart disease than it is for those without. The ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC